Friday, November 8, 2024
spot_img

India’s first intranasal vaccine for COVID gets DCGI approval

Date:

Share post:

spot_img
spot_img

New Delhi, Sep 6:  India’s first intranasal Covid vaccine by Bharat Biotech on Tuesday got the approval from the Drug Controller General of India for 18+ age group for restricted use in emergency situation.

Announcing the achievements, Union Health Minister Mansukh Mandaviya termed it a ‘big boost to India’s fight against Covid-19.

“Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation,” Mandaviya tweeted.

In the subsequent tweet he said, “This step will further strengthen our collective fight against the pandemic.

“India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji’s leadership. With the science-driven approach & Sabka Prayas, we will defeat COVID-19”, he said.

IANS
spot_img
spot_img

Related articles

Sinner, Alcaraz headline ATP Finals; injured Djokovic out

Turin, Nov 7: Jannik Sinner and Carlos Alcaraz are poised to add another entry into their rapidly developing...

Harmanpreet sole Indian for WBBL Team of the Decade

Melbourne, Nov 7: Captain Harmnapreet Kaur is the only Indian player in the 50-player shortlist for the Women’s...

Franchises retain big names

New Delhi, Nov 7: Smriti Mandhana, Ellyse Perry, Shafali Verma, Meg Lanning and Harmanpreet Kaur were some of...

Mumbai cops dispatched to Raipur in search of man who threatened SRK

A person who threatened Bollywood icon Shah Rukh Khan has been traced to Raipur in Madhya Pradesh. A case...